Genome-wide classification of tumor-derived reads from bulk long-read sequencing

Toby M Baker1, Nedas Matulionis1, Cassidy Andrasz1,2

  • 1Division of Hematology Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles.

Insights

Researchers developed ROCIT, a transformer model for classifying DNA origin in bulk tumors. This method uses methylation patterns from long-read sequencing to distinguish tumor from non-tumor cells genome-wide, improving variant calling.

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Bulk tumor DNA is a mixture of cell types, making cell-type origin determination difficult without single-cell analysis.
  • Human neoplasms present a complex cellular environment where distinguishing tumor from non-tumor DNA is challenging.

Purpose of the Study:

  • To develop a computational model (ROCIT) for classifying the origin of individual DNA reads from bulk tumor samples.
  • To enable accurate genome-wide classification of reads originating from tumor versus non-tumor cells using long-read sequencing data.

Main Methods:

  • Developed ROCIT, a transformer-based model utilizing read-level methylation patterns for classification.
  • Trained ROCIT using somatic mutations identified in bulk tumor samples.
  • Applied ROCIT to long-read whole genome sequencing data from prostate and ovarian tumors.

Main Results:

  • ROCIT achieved high classification accuracy for read origin (tumor vs. non-tumor) across the entire genome.
  • The model accurately classifies reads without needing adjacent normal tissue or pre-identified differentially methylated regions.
  • ROCIT predictions demonstrated potential to enhance somatic variant calling accuracy.

Conclusions:

  • ROCIT is a significant advancement for analyzing bulk tumors using long-read sequencing.
  • The model facilitates accurate and sensitive identification of cell types of origin for DNA reads genome-wide.
  • This approach offers a powerful new tool for understanding tumor heterogeneity and improving genomic analyses.

Related Concept Videos